Perpetual Ltd’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.4M | Buy |
18,974
+891
| +5% | +$117K | 0.03% | 163 |
|
|
2026
Q1 | $2.52M | Sell |
18,083
-10,415
| -37% | -$1.46M | 0.04% | 150 |
|
|
2025
Q4 | $3.5M | Buy |
28,498
+15,422
| +118% | +$1.87M | 0.05% | 141 |
|
|
2025
Q3 | $1.45M | Buy |
13,076
+915
| +8% | +$104K | 0.02% | 219 |
|
|
2025
Q2 | $1.35M | Sell |
12,161
-2,478
| -17% | -$264K | 0.02% | 222 |
|
|
2025
Q1 | $1.64M | Sell |
14,639
-1,515
| -9% | -$156K | 0.02% | 215 |
|
|
2024
Q4 | $1.49M | Hold |
16,154
| – | – | 0.02% | 214 |
|
|
2024
Q3 | $1.35M | Hold |
16,154
| – | – | 0.01% | 231 |
|
|
2024
Q2 | $1.11M | Buy |
16,154
+2,260
| +16% | +$151K | 0.01% | 257 |
|
|
2024
Q1 | $1.02M | Buy |
13,894
+11
| +0.1% | +$846 | 0.01% | 279 |
|
|
2023
Q4 | $1.12M | Sell |
13,883
-30,026
| -68% | -$2.34M | 0.01% | 257 |
|
|
2023
Q3 | $3.29M | Sell |
43,909
-3,935
| -8% | -$303K | 0.03% | 180 |
|
|
2023
Q2 | $3.69M | Sell |
47,844
-5,555
| -10% | -$443K | 0.03% | 197 |
|
|
2023
Q1 | $4.43M | Buy |
+53,399
| New | +$4.42M | 0.04% | 192 |
|
|
2020
Q3 | $969K | Buy |
15,337
+937
| +7% | +$65K | 0.07% | 191 |
|
|
2020
Q2 | $1.11M | Buy |
+14,400
| New | +$1.1M | 0.1% | 131 |
|
|
2020
Q1 | – | Sell |
-14,400
| Closed | -$934K | – | 198 |
|
|
2019
Q4 | $934K | Hold |
14,400
| – | – | 0.14% | 76 |
|
|
2019
Q3 | $913K | Hold |
14,400
| – | – | 0.14% | 76 |
|
|
2019
Q2 | $973K | Sell |
14,400
-2,100
| -13% | -$138K | 0.15% | 68 |
|
|
2019
Q1 | $1.07M | Hold |
16,500
| – | – | 0.16% | 71 |
|
|
2018
Q4 | $1.02M | Hold |
16,500
| – | – | 0.15% | 72 |
|
|
2018
Q3 | $1.27M | Hold |
16,500
| – | – | 0.17% | 71 |
|
|
2018
Q2 | $1.17M | Buy |
16,500
+2,000
| +14% | +$141K | 0.14% | 74 |
|
|
2018
Q1 | $1.09M | Hold |
14,500
| – | – | 0.15% | 69 |
|
|
2017
Q4 | $1.05M | Buy |
14,500
+700
| +5% | +$53.2K | 0.14% | 75 |
|
|
2017
Q3 | $1.15M | Sell |
13,800
-162,100
| -92% | -$12.4M | 0.16% | 71 |
|
|
2017
Q2 | $12.4M | Buy |
175,900
+16,100
| +10% | +$1.07M | 0.97% | 25 |
|
|
2017
Q1 | $10.6M | Buy |
+159,800
| New | +$11.2M | 1.06% | 30 |
|
|
2016
Q4 | – | Sell |
-9,400
| Closed | -$744K | – | 161 |
|
|
2016
Q3 | $744K | Sell |
9,400
-14,400
| -61% | -$1.17M | 0.06% | 182 |
|
|
2016
Q2 | $1.99M | Buy |
23,800
+3,800
| +19% | +$337K | 0.2% | 106 |
|
|
2016
Q1 | $1.84M | Buy |
20,000
+3,800
| +23% | +$343K | 0.19% | 106 |
|
|
2015
Q4 | $1.64M | Buy |
16,200
+2,200
| +16% | +$229K | 0.18% | 103 |
|
|
2015
Q3 | $1.38M | Sell |
14,000
-700
| -5% | -$77.7K | 0.16% | 104 |
|
|
2015
Q2 | $1.72M | Buy |
+14,700
| New | +$1.61M | 0.2% | 98 |
|
Other funds holding GILD
ECSS
CIM
ATO
Perpetual Ltd's GILD Position: Q2 2026 in Review
Perpetual Ltd increased its Gilead Sciences (GILD) stake by 4.9% in Q2 2026, buying an estimated $117K and bringing the position to 18,974 shares worth $2.4M. The position accounts for 0.03% of the portfolio, ranked #163.
Perpetual Ltd first reported a position in GILD in Q2 2015 and has held it in 34 quarters since. The position peaked at $12.4M in Q2 2017. 879 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Perpetual Ltd held 18,974 shares of Gilead Sciences worth $2.4M as of Q2 2026.
- Perpetual Ltd bought 891 Gilead Sciences shares in Q2 2026, an estimated $117K.
- Gilead Sciences made up 0.03% of Perpetual Ltd's portfolio in Q2 2026, its #163 holding.
- Perpetual Ltd first reported a position in Gilead Sciences in Q2 2015 and has held it in 34 quarters since.
- Perpetual Ltd's Gilead Sciences position peaked at $12.4M in Q2 2017.
- 879 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Perpetual Ltd's 13F filing for Q2 2026, filed 15 Jul 2026.